For episode 5 of the pharmaphorum podcast Dominic Tyer met Blueberry Therapeutics’ CEO Dr John Ridden at The Wellcome Collection in London to talk about the UK biotech he co-founded, its strategy and bringing innovation to life through Blueberry’s nanomedicine approach.
Live from Frontiers Health 2022 - the pharmaphorum podcast
Live from Reuters Pharma 2022 - the pharmaphorum podcast
Building agile partner relationships at a vaccine-focused biotech
Understanding the tumour micro-environment – the pharmaphorum podcast
How a once-weekly insulin could disrupt diabetes management
How these parents of a child with a rare disease are making precision medicine work for them
AI-derived cancer vaccines
Challenges and opportunities in the off-patent sector
Building a digital therapeutic for paediatric behavioural health opioids
Gene silencing and mRNA: breakthroughs and barriers
Rethinking pharmaceutical pain management beyond opioids
Why diverse clinical trials matter
Where pharma stands on patient centricity, engagement, and trust
How pharma can spur innovation and promote health equity in mental health
Innovative solutions to the drug pricing crisis: the pharmaphorum podcast
Big data and how it can change the game in pharma: the pharmaphorum podcast
The year ahead in digital health and life sciences: the pharmaphorum podcast
The evolution of clinical trials: the pharmaphorum podcast
Patient engagement processes: the pharmaphorum podcast
Real-world evidence and qualitative research: the ELICIT podcast
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Unexplainable
Speaking of Psychology
Stuff To Blow Your Mind